imipramine has been researched along with Hepatocellular Carcinoma in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, YH | 1 |
| Yeh, CT | 1 |
| Dybing, E | 1 |
2 other studies available for imipramine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Anticancer Effects of Antidepressants in Hepatocellular Carcinoma Cells.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Carcinoma, Hepatocellular; Humans; | 2023 |
Effects of membrane stabilizers on glucuronidation and amino acid transport in cultures of rat hepatoma cells.
Topics: Alanine; Aminoisobutyric Acids; Animals; Antipsychotic Agents; Biological Transport; Carcinoma, Hepa | 1973 |